Squamous cell carcinoma (SCC) is frequently itchy. Studies consistently find that itch is the single most common symptom patients report with this cancer, occurring in roughly four to five out of every ten cases. That makes SCC itchier than basal cell carcinoma, the other major nonmelanoma skin cancer, and far itchier than melanoma. But the itch of skin cancer is easy to dismiss or misread, and understanding what drives it, how it compares to other conditions, and when it signals something more concerning is worth a closer look.
How Often SCC Causes Itching
The numbers are remarkably consistent across studies. One large clinicopathologic study found that itch was present in 46.6% of squamous cell carcinomas, the highest rate among the three major skin cancer types it examined.1JAMA Network. Association of Pain and Itch With Depth of Invasion and Inflammatory Cell Constitution in Skin Cancer: Results of a Large Clinicopathologic Study A separate study put the figure at 43.5%.2JAMA Dermatology. Itch and Pain in Nonmelanoma Skin Cancer: Pain as an Important Feature of Cutaneous Squamous Cell Carcinoma So while SCC does not itch in every case, itching is far from unusual. If you have a suspicious lesion that itches, that alone does not confirm cancer, but it certainly does not rule it out either.
The other side of this coin matters too. More than half of SCCs produce no itch at all. Some patients feel pain instead, some feel both, and some feel nothing. So the absence of itching is not reassuring. Many people assume that if a spot is not bothering them, it is probably harmless. The data suggest otherwise: symptom presence or absence is a poor guide for deciding whether a lesion needs medical attention.
What Makes SCC Itch
The itch associated with SCC is not random. Research has tied it directly to what is happening inside the tumor at a cellular level. The same large clinicopathologic study found that itch intensity correlated with the degree of inflammation around the tumor. Tumors with moderate-to-marked inflammation were significantly more likely to itch than those with little or no inflammation. Eosinophils, a type of immune cell, played a particularly strong role: when eosinophils were present in the tissue around the tumor, patients were roughly two and a half times more likely to report itch, and their itch intensity scores were higher.1JAMA Network. Association of Pain and Itch With Depth of Invasion and Inflammatory Cell Constitution in Skin Cancer: Results of a Large Clinicopathologic Study
Eosinophils release chemical mediators that activate itch-sensing nerve fibers in the skin. This is the same basic process behind the itch of allergic reactions, insect bites, and some inflammatory skin diseases, which is part of the reason a cancerous lesion’s itch can feel identical to a benign one. Your body is mounting an immune response to the abnormal cells, and a side effect of that immune activity is the sensation of itch. It is your immune system reacting to the tumor, not the tumor itself directly tickling your nerves.
This also explains why not all SCCs itch equally. Tumors that provoke a vigorous immune response with lots of inflammatory cells tend to itch more. Tumors that fly under the immune system’s radar, or that grow in a way that does not attract eosinophils, tend to be quieter. The biology of the itch is genuinely informative about what the immune system is doing in response to the cancer.
How SCC Compares to Other Skin Cancers
SCC is itchier than basal cell carcinoma, though the gap is not enormous. BCC itch rates in the literature run around 32 to 34%, compared to the 44 to 47% range for SCC.2JAMA Dermatology. Itch and Pain in Nonmelanoma Skin Cancer: Pain as an Important Feature of Cutaneous Squamous Cell Carcinoma Interestingly, while that difference looks meaningful on paper, at least one review noted it was not statistically significant, meaning the gap could partly reflect chance variation in the samples studied.3PubMed. Itch and pain intensity in skin cancer: Why should dermatologic surgeons assess it? What does clearly differ between SCC and BCC is pain: SCC is significantly more painful, a finding that has held up across multiple studies.
Melanoma stands apart from both. A study of elderly male patients found that 82% of melanomas were completely asymptomatic at diagnosis, meaning no itch, no pain, no bleeding, nothing. Basal cell carcinoma and squamous cell carcinoma were far more likely to produce symptoms.4PubMed. Evaluation of prospectively collected presenting signs/symptoms of biopsy-proven melanoma, basal cell carcinoma, squamous cell carcinoma, and seborrheic keratosis in an elderly male population This is worth knowing because melanoma is generally the more dangerous cancer. The lesson is counterintuitive: the skin cancer least likely to bother you is the one most likely to be life-threatening. Do not wait for symptoms before having a suspicious mole checked.
Even seborrheic keratoses, which are completely benign growths, can itch. That same study found they produced symptoms at rates roughly comparable to BCC. So itching alone cannot reliably distinguish between a harmless growth and a malignancy. The visual characteristics of the lesion and, ultimately, a biopsy are what matter for diagnosis.
When Itching Gets Mistaken for Something Else
One of the practical dangers of SCC-related itch is that it can lead to misdiagnosis. An itchy, scaly, reddish patch on the skin looks a lot like eczema, psoriasis, or a fungal infection. If a patient or their doctor assumes the itch is coming from one of these common conditions, the cancer underneath can go undetected for years.
A case report documented a patient with Bowen disease, the earliest form of SCC confined to the top layer of skin, that was treated as chronic eczema for nine years before a biopsy finally revealed the true diagnosis. The authors emphasized that persistent, treatment-resistant anogenital plaques should not be repeatedly managed as eczema without a biopsy to confirm what is actually going on. The longer the diagnostic delay, the greater the risk that the disease progresses from an in-situ stage to invasive squamous cell carcinoma.5Clinical Case Reports. Large Anogenital Bowen Disease Misdiagnosed as Chronic Eczema for Nine Years: A Case Report Highlighting the Importance of Early Biopsy
The practical takeaway is straightforward: if you have a patch of skin that itches persistently, looks scaly or reddened, and does not respond to standard eczema or antifungal treatments within a few weeks, ask about a biopsy. This is especially true for lesions in sun-exposed areas or in older adults with a history of sun damage, but it applies to any location. Itch that does not resolve with appropriate treatment for the presumed diagnosis is a red flag worth investigating.
Precancerous Lesions Itch Too
Actinic keratoses, the rough, scaly spots that are considered precursors to SCC, can also be itchy. They present as squamous, reddened patches, and while they can be completely asymptomatic, they often produce itch and sometimes pain.6PubMed Central. Clinical and Dermoscopic Diagnosis of Actinic Keratosis Since actinic keratoses sit on a continuum with SCC, with a small percentage progressing to invasive cancer over time, the itch from an actinic keratosis is not fundamentally different from the itch of early SCC. Both involve an area of abnormal skin cells provoking a local immune response.
Treatment of actinic keratoses can actually make the itching temporarily worse. Imiquimod cream, one of the standard topical therapies, works by ramping up the local immune response against the abnormal cells. The most common side effects of this treatment are redness, itching, and scabbing.7Journal of the American Academy of Dermatology. Clinical effect of imiquimod 5% cream in the treatment of actinic keratosis These reactions are generally mild to moderate and resolve after treatment ends, but patients should expect the treated area to feel more irritated and itchy before it feels better. Knowing this in advance prevents people from abandoning treatment because they assume the increased itch means something is going wrong.
Other treatments for actinic keratoses and superficial SCCs, including 5-fluorouracil cream and photodynamic therapy, can also cause temporary itch and irritation as part of their mechanism of action. In each case, the treatment is deliberately provoking inflammation to destroy abnormal cells, and itch is a predictable consequence of that process.
When SCC Symptoms Go Beyond Itch
In more advanced SCC, the symptom profile shifts. One particular concern is perineural invasion, where the cancer grows along or into nerves. This occurs in a subset of SCCs, particularly those that are larger, deeper, or located on the head and face where nerve density is high.
The early symptoms of perineural invasion are often subtle: a tingling or numb sensation in the area of the tumor. These can easily go unnoticed unless a clinician is specifically looking for them.8Actas Dermo-Sifiliográficas. Perineural Invasion in Cutaneous Squamous Cell Carcinoma As the invasion progresses, symptoms can escalate to pain, loss of sensation, and even paralysis of muscles controlled by the affected nerve. Facial nerve involvement can cause drooping of the lip, difficulty closing an eyelid, or numbness across a section of the face.
Perineural invasion changes the staging and treatment of SCC. It generally means the cancer requires wider surgical margins or adjuvant radiation therapy. More critically, it increases the risk of recurrence and metastasis. If you notice numbness, tingling, or weakness near a known or previously treated SCC, report those symptoms immediately rather than waiting for a routine follow-up.
How Itch Affects Sleep and Quality of Life
The itch from skin conditions, including skin cancers, is not just an annoyance. Research on dermatology patients broadly has shown that itch significantly disrupts sleep. A cross-sectional study found that about two-thirds of dermatology patients met the criteria for poor sleep, and itch intensity was a major contributor. Patients whose itch exceeded moderate intensity on a standard scale were at particularly high risk for sleep disturbance. The itch also tended to worsen at night, compounding the problem.9PubMed. Sleep disturbance in adult dermatologic patients: A cross-sectional study on prevalence, burden, and associated factors
That same study found something else worth noting: psychological distress had an even larger impact on sleep than the itch itself, and nearly a third of the relationship between itch intensity and sleep problems was mediated through psychological distress.9PubMed. Sleep disturbance in adult dermatologic patients: A cross-sectional study on prevalence, burden, and associated factors In other words, it is not just the physical sensation keeping people up. The worry and anxiety that come with persistent itch, especially when it might be associated with a cancer diagnosis, amplify the sleep disruption. This creates a feedback loop: poor sleep worsens anxiety, which worsens the perception of itch, which further disrupts sleep.
If you are dealing with itch from an SCC or a suspicious lesion, addressing the itch is not a trivial concern. Cool compresses, fragrance-free moisturizers, and topical anti-itch preparations can help. Mention the itch to your dermatologist, who may recommend a targeted approach depending on whether the itch is from the tumor itself, from surrounding inflammation, or from treatment. Managing it is part of managing the disease.
Itch as a Diagnostic Clue, Not a Diagnosis
Dermatologists have debated whether itch or pain could serve as useful screening signals for skin cancer. The evidence so far suggests these symptoms add some information but are nowhere near reliable enough to guide decisions on their own. SCC is the itchiest of the common skin cancers, but it itches at a rate only modestly higher than BCC, and many completely benign conditions itch at equal or higher rates. Pain is more discriminating: SCC is significantly more painful than BCC, and any skin lesion that hurts without an obvious reason, such as recent trauma, deserves a closer look.3PubMed. Itch and pain intensity in skin cancer: Why should dermatologic surgeons assess it?
The argument for routinely asking about symptoms during skin exams is not that itch or pain will catch cancers that visual inspection misses. It is that symptoms provide context. A lesion that itches and has been growing warrants more urgency than one that has sat unchanged for years. A lesion that hurts might prompt a biopsy of something that looked borderline on visual inspection alone. And tracking symptoms over time can help catch recurrences: if a previously treated site starts itching or hurting again, that change is clinically meaningful even if the site does not yet look abnormal.
For patients, the most useful version of this information is simple: do not ignore persistent itch on a specific patch of skin, especially if the spot is also changing in appearance, feels rough or scaly, or does not heal. Itch alone does not mean cancer. But itch plus visual changes plus persistence is a combination that earns a visit to a dermatologist and likely a biopsy. The earlier SCC is caught, the simpler the treatment and the better the outcome.